Status:
COMPLETED
DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
A comparison of the ability of DisCoVisc to that of other ophthalmic viscosurgical devices (OVDs) (DuoVisc, Healon5 or Amvisc PLUS) regarding endothelial protection and anterior chamber space maintena...
Eligibility Criteria
Inclusion
- operable cataracts in at least one eye
Exclusion
- Endothelial Cell Count (ECC) ≤1500cells/mm2
- Intraocular Pressure (IOP) \> 21mm Hg
- previous ocular inflammation
- systemic or ocular conditions affecting corneal endothelium
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT00712244
Start Date
October 1 2007
Last Update
September 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center for Study Locations
Fort Worth, Texas, United States, 76134